Psychedelic medicine: safety and ethical concerns.
Brian T Anderson, Alicia Danforth, Charles S. Grob
Lancet Psychiatry October 1, 2020 DOI: 10.1016/s2215-0366(20)30146-2 (opens in new tab) via PubMed
Summary
AI-generated from the abstractThe text discusses safety and ethical concerns surrounding psychedelic medicine, emphasizing the need for stringent oversight, comprehensive patient screening, robust therapeutic support, and informed consent to mitigate risks such as psychological distress and misuse. It highlights the ethical imperative for equitable access and responsible medical use as these powerful medicines are integrated into clinical practice.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Powerful medicines Safety protocols Patient well-being Risks |
| Citations | 99 |
| Key finding | Psychedelic medicine requires stringent oversight, comprehensive patient screening, robust therapeutic support, and informed consent to address safety and ethical concerns. |
Abstract
Psychedelic medicine: safety and ethical concerns.